Welltower Inc Stock Price, News & Analysis

Welltower Inc. (NYSE: WELL) has released a business update in preparation for upcoming investor meetings. The update, which contains important information for shareholders and potential investors, is now available on the company's official website. Interested parties can access the full details of the update at https://welltower.com/October2024-business-update.

This proactive communication demonstrates Welltower's commitment to transparency and keeping stakeholders informed about the company's current business status and future prospects. The update likely includes key financial metrics, operational highlights, and potentially strategic initiatives or market insights relevant to Welltower's position in the healthcare real estate sector.

Welltower Inc. (NYSE: WELL) has announced its participation in the Bank of America Securities 2024 Global Real Estate Conference. Chief Executive Officer Shankh Mitra will be part of a live panel discussion scheduled for Tuesday, September 10, 2024, from 2:15 p.m. to 2:50 p.m. ET. The event will take place at the Bank of America Tower in New York City.

Interested parties can access the webcast of the panel discussion through a provided link. This conference participation highlights Welltower's engagement with the investment community and offers an opportunity for stakeholders to gain insights into the company's strategies and market position in the real estate sector.

Welltower Inc. (NYSE: WELL) has announced the appointment of Andrew Gundlach to its Board of Directors. Gundlach, 53, is the President and Co-CEO of Bleichroeder LP, a registered investment advisor. He brings nearly 30 years of investment experience and expertise in corporate strategy and capital markets. Gundlach has been a board member at First Eagle Investment Management since 2004 and played a key role in spinning off Bleichroeder. His background includes roles at Morgan Stanley and J.P. Morgan.

Kenneth J. Bacon, Chairman of Welltower's Board, highlighted Gundlach's broad skillset and alignment with the company's long-term investment orientation. Gundlach's appointment is expected to complement the Board's capabilities and contribute to Welltower's portfolio expansion and shareholder value enhancement efforts.

Welltower Inc. (NYSE: WELL) has closed on an amended $5.0 billion senior unsecured revolving line of credit, strengthening its liquidity position and extending its debt maturity profile. The facility includes a $3.0 billion tranche maturing in 2028 and a $2.0 billion tranche maturing in 2029. This follows recent positive credit rating outlook revisions by S&P Global and Moody's. The new facility offers improved pricing, with loans currently bearing interest at 72.5 basis points over the adjusted SOFR rate and an annual facility fee of 12.5 basis points. Welltower's total available credit facilities now reach approximately $7.5 billion, positioning the company for continued growth and disciplined capital allocation.

Welltower Inc. (NYSE: WELL) has released a business update on July 29, 2024. The update, which provides insights into the company's current operations and financial status, is available for viewing on the company's official website. Welltower, a leading real estate investment trust specializing in healthcare infrastructure, regularly issues such updates to keep investors and stakeholders informed about its performance and strategic initiatives.

While specific details of the update are not provided in the press release, interested parties can access the full report at the provided link. These updates typically cover areas such as occupancy rates, revenue trends, acquisition activities, and any significant developments in Welltower's portfolio of healthcare properties.

Welltower Inc. (NYSE:WELL) reported strong Q2 2024 results, with net income of $0.42 per diluted share and normalized FFO of $1.05 per diluted share, up 16.7% year-over-year. The company saw total portfolio SSNOI growth of 11.3%, driven by a 21.7% increase in Seniors Housing Operating. Welltower completed $1.7 billion in pro rata gross investments and has $4.9 billion in acquisitions and loan funding closed or under agreement since the start of the year. The company's balance sheet strengthened with net debt to Adjusted EBITDA of 3.68x and $6.9 billion in available liquidity. The Board approved a 10% increase in quarterly dividend, reflecting strong financial performance and growth prospects.

Welltower (NYSE: WELL) will release its second quarter 2024 financial results after the close of trading on July 29, 2024.

A conference call and webcast to discuss the results is scheduled for July 30, 2024, at 9:00 a.m. ET.

The earnings release will be available in the Investors section of Welltower's website.

Investors can access the call via the company's website at www.welltower.com or through a webcast at https://events.q4inc.com/attendee/528114084.

A replay of the webcast will be available approximately two hours after the call and will remain accessible for 90 days.

Telephone access is also provided, with dial-in numbers available for both U.S. and international participants.

Replays of the call will be accessible until August 6, 2024.

Welltower has announced the successful closing of its $1.035 billion offering of 3.125% exchangeable senior notes due 2029. The offering, aimed at qualified institutional buyers, saw full exercise of the initial purchasers' option for additional notes. The notes are senior unsecured obligations, paying semi-annual interest and maturing in July 2029. They can be exchanged for cash or Welltower common stock based on a specific exchange rate. Welltower plans to use the proceeds for general purposes, including debt repayment and investing in healthcare and senior housing properties.

Welltower announced the pricing and upsizing of its offering of $900 million in 3.125% exchangeable senior notes due 2029. The offering was upsized from the previously announced amount and will close on July 11, 2024, subject to conditions. The notes, to be sold to institutional buyers, will accrue interest at 3.125% annually and mature on July 15, 2029, unless exchanged or redeemed earlier. Welltower OP has also granted initial purchasers an option to buy an additional $135 million in notes. Proceeds estimated at $882.3 million will be used for corporate purposes, including debt repayment and investments in healthcare properties. Notes will be exchangeable for cash or Welltower common stock and may be redeemed under specific conditions. The exchange rate is initially set at 7.8177 shares per $1,000 principal, with a 22.5% premium on the share price of $104.42 as of July 8, 2024.